Research Paper Volume 15, Issue 9 pp 3480—3497
A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Figure 8. The distinct immune infiltration features of TME between low- and high-risk groups. (A) Distribution of the relative abundance of immune cells in different risk groups. (B) Correlation analysis of immune infiltrating cells and risk scores. (C) Correlation analysis of immune infiltrating cells and CAB39L. (D) Correlation analysis of immune infiltrating cells and DLGAP5. (E) Correlation analysis of immune infiltrating cells and HBA2. (F) Correlation analysis of immune infiltrating cells and SLC16A6. (G) Correlation analysis of immune infiltrating cells and BUB1.